Detalhe da pesquisa
1.
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol
; 202(3): 525-529, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217196
2.
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.
Blood Adv
; 4(2): 253-262, 2020 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945157